Quantitative analysis of olanzapine in rat brain microdialysates by HPLC-MS/MS coupled with column-switching technique

被引:14
作者
Zheng, Qiaoling [1 ,2 ]
Wang, Feng [1 ]
Li, Huande [1 ]
Xu, Ping [1 ]
Tang, Huaibo [3 ]
Li, Lanfang [1 ]
Cheng, Rihua [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Clin Pharm & Pharmacol Res Inst, Changsha 410011, Hunan, Peoples R China
[2] Kunming Med Univ, Affiliated Hosp 1, Ctr Clin Pharm, Kunming 650032, Peoples R China
[3] Xiangtan Univ, Sch Chem, Xiangtan 411105, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2012年 / 905卷
关键词
Olanzapine; HPLC-MS/MS; Microdialysis; Schisandra sphenanthera Rehd. et Wils; PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY METHOD; HUMAN PLASMA; RISPERIDONE; 9-HYDROXYRISPERIDONE; DESMETHYLOLANZAPINE; INHIBITORS; CLOZAPINE; VERAPAMIL; DRUGS;
D O I
10.1016/j.jchromb.2012.07.024
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
A rapid and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method coupled with column-switching technique was developed for the determination of olanzapine in rat brain microdialysates. A C8 guard column was used to desalt the samples before analytical separation on a C18 column and detection with tandem mass spectrometry. The mobile phase consisted of methanol/acetonitrile/water (v/v/v, 22.5/22.2/55) was used for desalting and the mobile phase consisted of methanol/acetonitrile/water (v/v/v, 43/43/14) was for analytical separation, water in both mobile phases contained 0.1% ammonium acetate. The lower limit of quantification (LLOQ) for olanzapine was 0.085 ng/ml. The method was linear from LLOQ to 34 ng/ml with a coefficient of determination >0.998. Intra- and inter-day accuracy and precision were determined with variability Less than 13.24% (R.S.D). This sensitive method was successfully applied to quantify the concentration of olanzapine in rat brain microdialysates. With this study, the effect of the alcohol extract of Schisandra sphenanthera Rehd. et Wils on the concentration of olanzapine in brain was investigated. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 25 条
[1]
Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO
[2]
2-6
[3]
Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia [J].
Bebawy, Mary ;
Chetty, Manoranjenni .
BIOESSAYS, 2008, 30 (02) :183-188
[4]
Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma [J].
Belpomme, D ;
Gauthier, S ;
Pujade-Lauraine, E ;
Facchini, T ;
Goudier, MJ ;
Krakowski, I ;
Netter-Pinon, G ;
Frenay, M ;
Gousset, C ;
Marié, FN ;
Benmiloud, M ;
Sturtz, F .
ANNALS OF ONCOLOGY, 2000, 11 (11) :1471-1476
[5]
In vitro P-glycoprotein affinity for atypical and conventional antipsychotics [J].
Boulton, DW ;
DeVane, CL ;
Liston, HL ;
Markowitz, JS .
LIFE SCIENCES, 2002, 71 (02) :163-169
[6]
Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS [J].
Choong, Eva ;
Rudaz, Serge ;
Kottelat, Astrid ;
Guillarme, Davy ;
Veuthey, Jean-Luc ;
Eap, Chin B. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 50 (05) :1000-1008
[7]
Determination of olanzapine in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection [J].
D'Arrigo, Concetta ;
Migliardi, Gaetana ;
Santoro, Vincenza ;
Spina, Edoardo .
THERAPEUTIC DRUG MONITORING, 2006, 28 (03) :388-393
[8]
Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds -: implications for pharmaccokinetics of selected substrates [J].
El Ela, AA ;
Härtter, S ;
Schmitt, U ;
Hiemke, C ;
Spahn-Langguth, H ;
Langguth, P .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (08) :967-975
[9]
Gopinath S., 2011, BIOMED CHROMATOGR
[10]
Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid [J].
Josefsson, Martin ;
Roman, Markus ;
Skogh, Elisabeth ;
Dahl, Marja-Liisa .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 53 (03) :576-582